Lysosome impairment as a trigger for inflammation in obesity: The proof is in the fat.
David R. Rawnsley,
Abhinav Diwan
Affiliations
David R. Rawnsley
Cardiolovascular Division, Washington University School of Medicine, Division of Cardiology, 660 S. Euclid, CSRB 827 NTA, St. Louis, MO 63110, United States; Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, MO, United States
Abhinav Diwan
Cardiolovascular Division, Washington University School of Medicine, Division of Cardiology, 660 S. Euclid, CSRB 827 NTA, St. Louis, MO 63110, United States; Center for Cardiovascular Research, Washington University School of Medicine, St. Louis, MO, United States; John Cochran Veterans Affairs Medical Center, St. Louis, MO, United States; Corresponding author.
Obesity is a global epidemic contributing to the rising prevalence of multiple disorders including metabolic syndrome, diabetes, fatty liver disease, cardiovascular and cerebrovascular disease, Alzheimer's disease and certain cancers. A renewed sense of urgency is required as obesity remains an intractable problem, despite a rapidly expanding armamentarium of behavioral, pharmacologic and surgical approaches which fall short of delivering sustained results